Drug Type Chemical drugs |
Synonyms 3,4-cPP, AX 0076, AX-0076 + [1] |
Target |
Action agonists, modulators |
Mechanism S1PR1 agonists(Sphingosine 1-phosphate receptor Edg-1 agonists), SIRT1 modulators(NAD-dependent deacetylase sirtuin 1 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | South Korea | 01 Jul 2025 | |
Nonalcoholic Steatohepatitis | Preclinical | South Korea | 01 Jul 2025 | |
Respiratory Distress Syndrome, Acute | Preclinical | South Korea | 01 Jul 2025 | |
Sepsis | Preclinical | South Korea | 01 Jul 2025 |